Predictors of first-fill adherence for patients with hypertension

American Journal of Hypertension

Volumn 22, Issue 4, 2009, Pages 392-396

  Shah, Nirav R ^a,b   Hirsch, Annemarie G ^a   Zacker, Christopher ^c   Wood, G Craig ^a   Schoenthaler, Antoinette ^b   Ogedegbe, Gbenga ^b   Stewart, Walter F ^a  

^a GEISINGER MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL STUDY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; COMORBIDITY; FEES, PHARMACEUTICAL; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PENNSYLVANIA; RETROSPECTIVE STUDIES;

EID: 62849103057     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.367     Document Type: Article

References (18)

1. High blood pressure statistics. 〈http://www.americanheart.org/ presenter. jhtml?identifier=2139〉 (2006). Accessed 7 May 2008.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
4. Neutel JM, Smith DH. Improving patient compliance: a major goal in the management of hypertension. J Clin Hypertens (Greenwich) 2003; 5:127-132.
5. Bosworth HB, Dudley T, Olsen MK, Voils CI, Powers B, Goldstein MK, Oddone EZ. Racial differences in blood pressure control: potential explanatory factors. Am J Med 2006; 119:70.e9-70.e15.
6. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epi 2003; 56:520-529.
7. World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization: Geneva, 2003.
8. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004; 42:649-652.
9. Sclar DA. Improving medication compliance: a review of selected issues. Clin Ther 1991; 13: 436-440.
10. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005; 19: CD000011.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
12. Thier SL, Yu-Isenberg KS, Leas BF, Cantrell CR, DeBussey S, Goldfarb NI, Nash DB. In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines. Manag Care 2008; 17:48-52, 55-57.
13. Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States. J Clin Hypertens (Greenwich) 2007; 9:692-700.
14. Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm 2007; 64:1279-1283.
15. Cooke CE, Fatodu H. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. J Manag Care Pharm 2006; 12:649-655.
16. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care 1997; 35:1119-1131.
17. Babazono A, Tsuda T, Yamamoto E, Mino Y, Une H, Hillman AL. Effects of an increase in patient copayments on medical service demands of the insured in Japan. Int J Technol Assess Health Care 2003; 19:465-475.
18. National Committee for Quality Assurance (NCQA). HEDIS 2008: Healthcare Effectiveness Data & Information Set. Vol. 2, Technical Specifications. Washington (DC). http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc- id=10035